ZETA-1 Phase 2 Trial to Determine the Safety and Efficacy of APX3330: a Novel, Oral Ref-1 Inhibitor for the Treatment of Diabetic Retinopathy Daniel Su,Jay Pepose, Mark Kelley,Audrey Lazar, Louis Haddad,Mina Sooch,Mitchell Brigell,Peter Kaiser,David BoyerINVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE（2023）引用 0|浏览4暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
